Stay updated on Intratumoral SD-101 + Pembrolizumab Clinical Trial
Sign up to get notified when there's something new on the Intratumoral SD-101 + Pembrolizumab Clinical Trial page.

Latest updates to the Intratumoral SD-101 + Pembrolizumab Clinical Trial page
- Check5 days agoChange DetectedThe study page is now blocked by a 403 error, showing only an error screen instead of the full study record and documents.SummaryDifference21%

- Check12 days agoChange DetectedRevision tag updated from v3.6.6 to v3.7.0 on the page, signaling an underlying update to the document version. This reflects an administrative or content-management update rather than a substantive change to study details.SummaryDifference0.0%

- Check19 days agoNo Change Detected
- Check54 days agoChange DetectedThe page now displays Revision: v3.6.5 instead of v3.6.4. This reflects a new release version of the site and does not change any study content.SummaryDifference0.0%

- Check68 days agoChange DetectedThe page now shows Revision: v3.6.4, replacing Revision: v3.6.3, indicating a version update to the page template or underlying site system.SummaryDifference0.0%

- Check90 days agoChange DetectedRevision label on the page updated from v3.6.1 to v3.6.3, reflecting a newer site revision. No study details or content were modified.SummaryDifference0.0%

- Check97 days agoChange Detected- Revision in the page footer updated from v3.6.0 to v3.6.1, signaling a new site release. This is a minor update and does not modify the study content or how users interact with the page.SummaryDifference0.0%

Stay in the know with updates to Intratumoral SD-101 + Pembrolizumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Intratumoral SD-101 + Pembrolizumab Clinical Trial page.